PeptidePedia The community reference

Special:RecentChanges

Change log·6,798 revisions·page 47 of 68

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 6,798 changes are logged in total.

6,798Logged changes
575Bot edits
167Page creations
256Active editors

23 February 2025

  1. (diff | hist) 23:06 Retention time 3,306 ±0 AAA_Analyst (talk | contribs) fix hyphenation per PP:MOS [rollback]
  2. (diff | hist) m b 19:56 Counterfeit peptide 2,733 ±0 StubSorterBot (talk | contribs) bot: normalise citation format [rollback]
  3. (diff | hist) m 19:45 Contraindications of incretin therapy 3,408 +34 Chromatokid (talk | contribs) move a stray full stop inside the reference [rollback]
  4. (diff | hist) 15:09 Cagrilintide 3,187 +40 IcodecIndra (talk | contribs) split §Pharmacology into receptor binding and downstream signalling [rollback]
  5. (diff | hist) 13:52 Intention-to-treat analysis 3,795 ±0 EndpointEnid (talk | contribs) give the primary endpoint as pre-specified, not as reported [rollback]
  6. (diff | hist) m 11:23 Drug master file 3,076 +811 FiveOhThreeB (talk | contribs) serial comma per PP:MOS [rollback]
  7. (diff | hist) 10:03 Peptide synthesis 4,113 ±0 FerritinFay (talk | contribs) add the customs-detention point as a logistics fact, sourced [rollback]
  8. (diff | hist) m 10:02 Underfilling 2,520 +32 ForestPlotFinn (talk | contribs) state what the certificate actually carries, field by field [rollback]
  9. (diff | hist) 09:16 Nantong Guangyuan Chemical 8,989 +874 UnderfillUna (talk | contribs) rm the discount code added by an anonymous editor [rollback]
  10. (diff | hist) 03:04 Karl Fischer titration 6,559 ±0 AnalyticalAnnie (talk | contribs) add the detection wavelength [rollback]
  11. (diff | hist) m b 02:42 Trifluoroacetate counterion 3,489 +25 StubSorterBot (talk | contribs) bot: sort category members [rollback]

22 February 2025

  1. (diff | hist) 21:10 Peptide supply chain 5,316 +135 NPOV_Nadia (talk | contribs) alphabetise the see-also list [rollback]
  2. (diff | hist) 21:07 Research use only 6,689 ±0 FmocFrancis (talk | contribs) state that a GMP claim is not a fact until assessed [rollback]
  3. (diff | hist) 09:58 Enteroendocrine L cell 4,619 ±0 FiveOhThreeB (talk | contribs) add the reference range with the assay it was established on [rollback]
  4. (diff | hist) m b 08:18 Weight regain after discontinuation 4,031 +335 ArchiveBot (talk | contribs) bot: add maintenance category [rollback]
  5. (diff | hist) 00:37 Wuhan Wansheng Biotechnology 9,762 +529 ForgeryFinder (talk | contribs) alphabetise the see-also list [rollback]
  6. (diff | hist) m 00:31 Peptide aggregation 4,028 +127 PreregPriya (talk | contribs) add the reference standard and its traceability [rollback]

21 February 2025

  1. (diff | hist) m b 22:29 GL Biochem (Shanghai) 10,789 +483 StubSorterBot (talk | contribs) bot: update parent category chain [rollback]
  2. (diff | hist) m 22:21 Sterile water for injection 3,619 ±0 GramsNotUnitsGil (talk | contribs) give the worked example to two significant figures throughout [rollback]
  3. (diff | hist) m 19:45 Arcuate nucleus 4,321 +447 LCellLeif (talk | contribs) move the trial material out of §Physiology into the compound articles [rollback]
  4. (diff | hist) 19:27 Peptide content 6,078 +1,146 DiluentDiya (talk | contribs) add the equilibration time to the gradient description [rollback]
  5. (diff | hist) m b 17:46 Deamidation 3,531 ±0 ArchiveBot (talk | contribs) bot: repair redlinked category [rollback]
  6. (diff | hist) m b 16:25 Satiety signalling 4,441 ±0 CategoryBot (talk | contribs) bot: update parent category chain [rollback]
  7. (diff | hist) 04:05 TRIUMPH trial programme 3,495 ±0 COA_Colwyn (talk | contribs) typo [rollback]
  8. (diff | hist) m 02:36 Prior authorisation 2,250 ±0 ShortageShona (talk | contribs) convert the country price comparison to a table with a common currency [rollback]
  9. (diff | hist) 02:16 Oral semaglutide 3,519 ±0 DulaglutideDug (talk | contribs) fix the anchor on an internal link [rollback]
  10. (diff | hist) m 00:31 Body composition assessment 4,060 +707 A1c_Alder (talk | contribs) rm the extrapolation from a research assay to a clinical one [rollback]
  11. (diff | hist) m b 00:09 Mass spectrometry 4,327 ±0 CiteBot (talk | contribs) bot: flag bare reference [rollback]

20 February 2025

  1. (diff | hist) m 23:52 Area percent purity 6,569 +544 TallySheetTad (talk | contribs) add the plate-count expression and define its terms [rollback]
  2. (diff | hist) m 23:26 Bacteriostatic water 3,824 ±0 SyringeSybille (talk | contribs) fix a broken wikilink [rollback]
  3. (diff | hist) m 21:27 Vial filling and stoppering 3,667 +312 ForestPlotFinn (talk | contribs) close an unbalanced quotation mark [rollback]
  4. (diff | hist) 18:28 USP General Chapter 71 2,970 +35 LOD_Lorcan (talk | contribs) fix hyphenation per PP:MOS [rollback]
  5. (diff | hist) m 17:08 Resin cleavage 3,277 ±0 CrudePeptidePearl (talk | contribs) add the excursion tolerance with the study it derives from [rollback]
  6. (diff | hist) 15:14 Solid-phase peptide synthesis 4,279 ±0 BlankVialBo (talk | contribs) attribute the stability figure to the study and its duration [rollback]
  7. (diff | hist) m 14:11 Aspiration risk under anaesthesia 3,725 +117 SPPS_Sorrel (talk | contribs) split the gastrointestinal effects from the metabolic ones [rollback]
  8. (diff | hist) 11:48 Talk:GL Biochem (Shanghai) 1,170 +177 CDMO_Caradoc (talk | contribs) /* Upstream versus retail: is this the same kind of article? */ reply
  9. (diff | hist) 09:18 Talk:Area percent purity 959 +121 PeakShapePol (talk | contribs) /* Detection wavelength: 214 or 220? */ reply
  10. (diff | hist) 07:14 Certificate of analysis 6,396 ±0 ManualOfStyleMo (talk | contribs) add the citation for the blind-sampling discussion [rollback]
  11. (diff | hist) m 06:33 Receptor bias 3,517 +281 TitrationTheo (talk | contribs) consistent en dashes in ranges [rollback]
  12. (diff | hist) 04:03 Cost per milligram 2,123 ±0 TierTwoTansy (talk | contribs) rm the specific plan recommendation; out of scope [rollback]
  13. (diff | hist) m b 01:45 Third-party testing 5,770 +683 ArchiveBot (talk | contribs) bot: normalise citation format [rollback]

19 February 2025

  1. (diff | hist) 20:14 Residual solvent 3,736 ±0 KarlFischerKit (talk | contribs) add the peptide-content point: area percent alone cannot give a mass [rollback]
  2. (diff | hist) 20:06 Exenatide 4,288 +869 Chromatokid (talk | contribs) add category for the drug class [rollback]
  3. (diff | hist) 18:22 Shanghai Wibson Biotechnology 4,331 +1,443 CheckSumChase (talk | contribs) correct the regional-warehouse list — six sites, not five [rollback]
  4. (diff | hist) 15:44 Talk:Area percent purity 748 +274 GradientGus (talk | contribs) /* Detection wavelength: 214 or 220? */ reply
  5. (diff | hist) 14:22 List of GLP-1 receptor agonists 3,023 ±0 DefinedTermDov (talk | contribs) space between number and unit per PP:MOS [rollback]
  6. (diff | hist) 11:49 Bacterial endotoxin test 4,398 ±0 TitrationTheo (talk | contribs) close an unbalanced quotation mark [rollback]
  7. (diff | hist) 11:19 Insulin secretion 5,442 +887 DPP4_Dagmar (talk | contribs) add the reference range with the assay it was established on [rollback]
  8. (diff | hist) 11:07 Talk:Area percent purity 537 +181 IsocraticIla (talk | contribs) /* Detection wavelength: 214 or 220? */ new section
  9. (diff | hist) 09:14 Talk:GL Biochem (Shanghai) 959 +260 ScopeSeverin (talk | contribs) /* Upstream versus retail: is this the same kind of article? */ reply
  10. (diff | hist) 08:53 WuXi TIDES 9,682 ±0 FiveOhThreeB (talk | contribs) add the how-to-request-a-batch-record sentence to §Ordering and availability [rollback]
  11. (diff | hist) m 03:33 Amylin receptor agonist 3,622 +90 CommaCarys (talk | contribs) the storage condition applies to the unopened pen; say so [rollback]

18 February 2025

  1. (diff | hist) 23:44 Medutest 3,795 ±0 ChainCustodyChad (talk | contribs) fix a dangling clause [rollback]
  2. (diff | hist) m 21:25 International nonproprietary name 3,145 +356 Chromatokid (talk | contribs) expand §Relationship to trade and chemical names [rollback]
  3. (diff | hist) m 18:21 Active pharmaceutical ingredient 2,832 ±0 PharmDrafts (talk | contribs) move a stray full stop inside the reference [rollback]
  4. (diff | hist) m 16:11 Albumin binding half-life extension 4,872 +361 ProglucagonPia (talk | contribs) the article treated a rodent finding as human physiology; corrected [rollback]
  5. (diff | hist) 14:33 Talk:GL Biochem (Shanghai) 748 +234 ParentCatPansy (talk | contribs) /* Upstream versus retail: is this the same kind of article? */ reply
  6. (diff | hist) 10:07 Talk:GL Biochem (Shanghai) 537 +264 CDMO_Caradoc (talk | contribs) /* Upstream versus retail: is this the same kind of article? */ new section
  7. (diff | hist) 09:33 Talk:Lyophilisation 1,455 +193 Ref_Desk_Ron (talk | contribs) /* Requested move: → Lyophilization */ reply

17 February 2025

  1. (diff | hist) 23:44 Number needed to treat 3,631 +390 FlowTrialFraser (talk | contribs) cite the trial publication rather than the sponsor press release [rollback]
  2. (diff | hist) 20:48 Global access disparity 2,619 +48 ClinicCorrespondent (talk | contribs) add the currency and the date to every price figure [rollback]
  3. (diff | hist) 15:28 ChinaPeptides 6,863 +335 SarcopeniaSefa (talk | contribs) add the minimum order quantity for custom synthesis [rollback]
  4. (diff | hist) m 10:41 GLP-1 receptor agonist 9,254 ±0 ReceptorRhoda (talk | contribs) move the trade-name history out of the lead and into §Regulatory history [rollback]
  5. (diff | hist) 09:53 Hypoglycaemia 3,743 +266 LeanMassLars (talk | contribs) state that no head-to-head comparison of tolerability exists for these two [rollback]
  6. (diff | hist) 09:22 Baseline laboratory panel 2,965 +592 DEXA_Dilys (talk | contribs) alphabetise the see-also list [rollback]
  7. (diff | hist) m 06:48 Adverse effects of GLP-1 receptor agonists 4,695 +213 LeanMassLars (talk | contribs) fix hyphenation per PP:MOS [rollback]
  8. (diff | hist) 03:59 Limit of detection 3,971 ±0 BatchNumberBede (talk | contribs) add the plate-count expression and define its terms [rollback]

16 February 2025

  1. (diff | hist) m 23:45 LEADER trial 3,537 +260 SurmountSurma (talk | contribs) rm a duplicated category [rollback]
  2. (diff | hist) 22:38 Sangon Biotech 5,296 +301 ChainCustodyChad (talk | contribs) copyedit [rollback]
  3. (diff | hist) m 14:30 Methionine oxidation 3,476 +796 DiluentDiya (talk | contribs) expand §Interpretation on a certificate [rollback]
  4. (diff | hist) 13:33 Personal importation policy 3,006 +774 StateBoardStace (talk | contribs) add the patent-expiry statement, attributed and dated [rollback]
  5. (diff | hist) 13:20 Placebo-adjusted effect 3,671 +784 ITT_Imelda (talk | contribs) fix a broken wikilink [rollback]
  6. (diff | hist) m 11:26 SURMOUNT trial programme 3,559 +289 GlossaryGleb (talk | contribs) add the discontinuation rate for adverse events in both arms [rollback]
  7. (diff | hist) 09:47 Preparative HPLC purification 3,866 ±0 UnitsUrsula (talk | contribs) add the collapse-temperature point, sourced [rollback]
  8. (diff | hist) m 09:28 Customs seizure 2,986 +591 PharmDrafts (talk | contribs) ce, tighten prose [rollback]
  9. (diff | hist) 09:25 Glucagon-like peptide-1 10,192 +175 DPP4_Dagmar (talk | contribs) add the counter-regulatory glucagon point, sourced [rollback]
  10. (diff | hist) 07:15 Qingdao Sigma Chemical 8,835 +1,357 BlankVialBo (talk | contribs) add the reception tally with its period and count stated [rollback]
  11. (diff | hist) 01:52 Multi-dose vial 4,366 +1,505 DrTitration (talk | contribs) expand §Reconstituted peptides and multiple withdrawal [rollback]
  12. (diff | hist) m b 01:20 Triple agonist 3,242 +95 CiteBot (talk | contribs) bot: normalise citation format [rollback]

15 February 2025

  1. (diff | hist) 23:54 Electrospray ionisation 3,226 ±0 AAA_Analyst (talk | contribs) typo [rollback]
  2. (diff | hist) 18:03 GLP-1 receptor 6,105 +583 SatietySunniva (talk | contribs) add a figure for the secretion time course and caption it [rollback]
  3. (diff | hist) m b 16:04 Peptide stability table 3,601 +1,517 CiteBot (talk | contribs) bot: normalise unit spacing [rollback]
  4. (diff | hist) m 14:46 Custom peptide synthesis 3,399 +150 CouplingCillian (talk | contribs) add the crimp-seal step to the fill-and-finish description [rollback]
  5. (diff | hist) 12:59 STEP trial programme 4,357 ±0 AnalyticalAnnie (talk | contribs) the article attributed a finding to the wrong trial in the programme [rollback]
  6. (diff | hist) 12:33 Dual incretin agonist 4,734 +147 BacWaterBarnaby (talk | contribs) add the year of first marketing authorisation, with the regulator named [rollback]
  7. (diff | hist) m 00:04 Amino acid analysis 2,621 ±0 Areapercent_Ayo (talk | contribs) fix a broken wikilink [rollback]

14 February 2025

  1. (diff | hist) 23:57 Batch number 3,708 ±0 VerifyVesna (talk | contribs) add the turnaround time the service publishes [rollback]
  2. (diff | hist) 13:25 SELECT trial 4,206 ±0 NNT_Nerys (talk | contribs) add the year of publication to each trial in the list [rollback]
  3. (diff | hist) 12:57 Semaglutide 8,079 +981 FreightFenna (talk | contribs) fix the anchor on an internal link [rollback]
  4. (diff | hist) m b 10:44 Bachem Holding (Suzhou) 8,095 +860 CategoryBot (talk | contribs) bot: sort category members [rollback]
  5. (diff | hist) 10:26 Talk:Chinese Peptide Company 1,033 +60 Hedgerow_Hal (talk | contribs) /* Requested move: → Chinese Peptide Company Co., Ltd. */ reply
  6. (diff | hist) 07:21 Reconstitution calculator 5,276 +820 SourceHunterSile (talk | contribs) add a second default preset at a common vial strength [rollback]

13 February 2025

  1. (diff | hist) 20:08 Dose escalation schedule 3,510 ±0 PreregPriya (talk | contribs) add the note that a smaller diluent volume raises concentration, not dose [rollback]
  2. (diff | hist) 19:12 VendorInvestigate 4,188 +603 SurrogateSunday (talk | contribs) rm the aggregate pass-rate figure; the denominator is not knowable [rollback]
  3. (diff | hist) m 17:34 Vial 17,729 +597 Chromatokid (talk | contribs) give the vial sizes in millilitres of nominal capacity [rollback]
  4. (diff | hist) 10:14 Talk:Lyophilisation 1,244 +262 LyophilLena (talk | contribs) /* Requested move: → Lyophilization */ reply
  5. (diff | hist) 06:57 Peptide harm reduction 2,785 ±0 ReaderRosalie (talk | contribs) expand §What the uncertainties are [rollback]
  6. (diff | hist) m 06:35 Reconstitution of lyophilised peptides 4,389 +216 TesamorelinTeg (talk | contribs) add the note that a smaller diluent volume raises concentration, not dose [rollback]
  7. (diff | hist) m 05:17 Orforglipron 3,337 ±0 LiraLotte (talk | contribs) typo [rollback]
  8. (diff | hist) 02:54 Regulatory status by jurisdiction 2,721 ±0 Areapercent_Ayo (talk | contribs) split overlong sentence [rollback]